GLAUKOS Corp Proceeds from Sale and Maturity of Marketable Securities
GLAUKOS Corp (GKOS) reported Proceeds from Sale and Maturity of Marketable Securities of $82.63 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2026-07-29
- GLAUKOS Corp proceeds from sale and maturity of marketable securities for the quarter ending 2026-06-30 was $36.05M, a 32.65% decline year-over-year.
- GLAUKOS Corp proceeds from sale and maturity of marketable securities for the quarter ending 2026-03-31 was $46.58M, a 13.94% increase year-over-year.
- GLAUKOS Corp proceeds from sale and maturity of marketable securities for the quarter ending 2025-12-31 was $27.98M, a 65.15% decline year-over-year.
- GLAUKOS Corp proceeds from sale and maturity of marketable securities for the quarter ending 2025-09-30 was $74.54M, a 14.40% increase year-over-year.
- GLAUKOS Corp proceeds from sale and maturity of marketable securities for fiscal 2025 was $196.94M, a 20.33% decline from fiscal 2024.
- GLAUKOS Corp proceeds from sale and maturity of marketable securities for fiscal 2024 was $247.20M, a 18.44% decline from fiscal 2023.
- GLAUKOS Corp proceeds from sale and maturity of marketable securities for fiscal 2023 was $303.10M, a 124.26% increase from fiscal 2022.
- GLAUKOS Corp proceeds from sale and maturity of marketable securities for fiscal 2022 was $135.16M, a 34.68% decline from fiscal 2021.
| Period end | Proceeds from Sale and Maturity of Marketable Securities 3 month | Proceeds from Sale and Maturity of Marketable Securities 6 month | Proceeds from Sale and Maturity of Marketable Securities 9 month | Proceeds from Sale and Maturity of Marketable Securities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $36.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $82.63M 10-Q · filed 2026-07-29 | $110.61M derived: sum of 3 quarters · filed 2026-07-29 | $185.16M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $46.58M 10-Q · filed 2026-04-30 | $74.56M derived: sum of 2 quarters · filed 2026-04-30 | $149.10M derived: sum of 3 quarters · filed 2026-04-30 | $202.63M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $27.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $102.53M derived: sum of 2 quarters · filed 2026-02-23 | $156.06M derived: sum of 3 quarters · filed 2026-07-29 | $196.94M 10-K · filed 2026-02-23 |
| 2025-09-30 | $74.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31 | $128.08M derived: sum of 2 quarters · filed 2026-07-29 | $168.95M 10-Q · filed 2025-10-31 | $249.26M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $53.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $94.41M 10-Q · filed 2026-07-29 | $174.72M derived: sum of 3 quarters · filed 2026-07-29 | $239.88M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $40.88M 10-Q · filed 2026-04-30 | $121.19M derived: sum of 2 quarters · filed 2026-04-30 | $186.35M derived: sum of 3 quarters · filed 2026-04-30 | $266.20M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $80.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $145.47M derived: sum of 2 quarters · filed 2026-02-23 | $225.32M derived: sum of 3 quarters · filed 2026-02-23 | $247.20M 10-K · filed 2026-02-23 |
| 2024-09-30 | $65.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31 | $145.01M derived: sum of 2 quarters · filed 2025-10-31 | $166.89M 10-Q · filed 2025-10-31 | $231.26M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-06-30 | $79.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $101.73M 10-Q · filed 2025-08-04 | $166.09M derived: sum of 3 quarters · filed 2026-02-23 | $207.92M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-03-31 | $21.88M 10-Q · filed 2025-05-01 | $86.25M derived: sum of 2 quarters · filed 2026-02-23 | $128.07M derived: sum of 3 quarters · filed 2026-02-23 | $235.08M derived: sum of 4 quarters · filed 2026-02-23 |
| 2023-12-31 | $64.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $106.19M derived: sum of 2 quarters · filed 2026-02-23 | $213.20M derived: sum of 3 quarters · filed 2026-02-23 | $303.10M 10-K · filed 2026-02-23 |
| 2023-09-30 | $41.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $148.83M derived: sum of 2 quarters · filed 2024-11-05 | $238.74M 10-Q · filed 2024-11-05 | $276.40M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $107.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $196.91M 10-Q · filed 2024-08-02 | $234.58M derived: sum of 3 quarters · filed 2025-02-25 | $275.32M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $89.90M 10-Q · filed 2024-05-03 | $127.56M derived: sum of 2 quarters · filed 2025-02-25 | $168.31M derived: sum of 3 quarters · filed 2025-02-25 | $207.88M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $37.66M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $78.41M derived: sum of 2 quarters · filed 2025-02-25 | $117.97M derived: sum of 3 quarters · filed 2025-02-25 | $135.16M 10-K · filed 2025-02-25 |
| 2022-09-30 | $40.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $80.31M derived: sum of 2 quarters · filed 2023-11-01 | $97.49M 10-Q · filed 2023-11-01 | $122.05M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-06-30 | $39.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $56.75M 10-Q · filed 2023-08-02 | $81.31M derived: sum of 3 quarters · filed 2024-02-23 | $159.97M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-03-31 | $17.18M 10-Q · filed 2023-05-04 | $41.74M derived: sum of 2 quarters · filed 2024-02-23 | $120.41M derived: sum of 3 quarters · filed 2024-02-23 | $173.75M derived: sum of 4 quarters · filed 2024-02-23 |
| 2021-12-31 | $24.56M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $103.22M derived: sum of 2 quarters · filed 2024-02-23 | $156.57M derived: sum of 3 quarters · filed 2024-02-23 | $206.92M 10-K · filed 2024-02-23 |
| 2021-09-30 | $78.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $132.01M derived: sum of 2 quarters · filed 2022-11-04 | $182.36M 10-Q · filed 2022-11-04 | $208.97M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-06-30 | $53.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $103.69M 10-Q · filed 2022-08-05 | $130.31M derived: sum of 3 quarters · filed 2023-02-24 | $163.38M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-03-31 | $50.35M 10-Q · filed 2022-05-05 | $76.96M derived: sum of 2 quarters · filed 2023-02-24 | $110.03M derived: sum of 3 quarters · filed 2023-02-24 | $135.37M derived: sum of 4 quarters · filed 2023-02-24 |
| 2020-12-31 | $26.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $59.69M derived: sum of 2 quarters · filed 2023-02-24 | $85.02M derived: sum of 3 quarters · filed 2023-02-24 | $104.70M 10-K · filed 2023-02-24 |
| 2020-09-30 | $33.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $58.41M derived: sum of 2 quarters · filed 2021-11-08 | $78.08M 10-Q · filed 2021-11-08 | $96.71M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $25.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $45.01M 10-Q · filed 2021-08-05 | $63.63M derived: sum of 3 quarters · filed 2022-02-28 | $84.44M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $19.68M 10-Q · filed 2021-05-06 | $38.30M derived: sum of 2 quarters · filed 2022-02-28 | $59.10M derived: sum of 3 quarters · filed 2022-02-28 | $83.98M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $18.62M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $39.42M derived: sum of 2 quarters · filed 2022-02-28 | $64.31M derived: sum of 3 quarters · filed 2022-02-28 | $80.49M 10-K · filed 2022-02-28 |
| 2019-09-30 | $20.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $45.68M derived: sum of 2 quarters · filed 2020-11-05 | $61.87M 10-Q · filed 2020-11-05 | $76.54M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $24.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $41.07M 10-Q · filed 2020-08-07 | $55.73M derived: sum of 3 quarters · filed 2021-03-01 | $73.50M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $16.19M 10-Q · filed 2020-05-07 | $30.86M derived: sum of 2 quarters · filed 2021-03-01 | $48.62M derived: sum of 3 quarters · filed 2021-03-01 | $70.94M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $14.67M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $32.43M derived: sum of 2 quarters · filed 2021-03-01 | $54.75M derived: sum of 3 quarters · filed 2021-03-01 | $78.85M 10-K · filed 2021-03-01 |
| 2018-09-30 | $17.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $40.09M derived: sum of 2 quarters · filed 2019-11-06 | $64.19M 10-Q · filed 2019-11-06 | $81.89M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $22.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $46.42M 10-Q · filed 2019-08-08 | $64.12M derived: sum of 3 quarters · filed 2020-03-02 | $90.73M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $24.10M 10-Q · filed 2019-05-08 | $41.80M derived: sum of 2 quarters · filed 2020-03-02 | $68.41M derived: sum of 3 quarters · filed 2020-03-02 | $87.73M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $17.70M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $44.31M derived: sum of 2 quarters · filed 2020-03-02 | $63.63M derived: sum of 3 quarters · filed 2020-03-02 | $88.89M 10-K · filed 2020-03-02 |
| 2017-09-30 | $26.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $45.93M derived: sum of 2 quarters · filed 2018-11-07 | $71.19M 10-Q · filed 2018-11-07 | $84.84M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $19.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $44.58M 10-Q · filed 2018-08-06 | $58.23M derived: sum of 3 quarters · filed 2019-02-28 | $75.98M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $25.26M 10-Q · filed 2018-05-09 | $38.91M derived: sum of 2 quarters · filed 2019-02-28 | $56.66M derived: sum of 3 quarters · filed 2019-02-28 | $65.01M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $13.65M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $31.40M derived: sum of 2 quarters · filed 2019-02-28 | $39.75M derived: sum of 3 quarters · filed 2019-02-28 | $55.35M 10-K · filed 2019-02-28 |
| 2016-09-30 | $17.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $26.10M derived: sum of 2 quarters · filed 2017-11-08 | $41.70M 10-Q · filed 2017-11-08 | |
| 2016-06-30 | $8.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $23.95M 10-Q · filed 2017-08-07 | ||
| 2016-03-31 | $15.60M 10-Q · filed 2017-05-04 | |||
| 2013-12-31 | $10.71M 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |